Industry Posters
Reduced Psychosocial Burden and High Patient Satisfaction Associated With Glabellar Lines Treatment With LetibotulinumtoxinA: BLESS Phase 3 Trials
Music City SCALE 2026
Michael H. Gold, MD
Popular Articles
Current Issue
June 2026
Volume 34
Issue 4


